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of autophagosome generation is marked by phosphatidylinositol 
3-phosphate (PI3) in membranes, which is deposited there by type 
III PI3 kinase complexes, containing the PI3 kinase VPS34, VPS15, 
Atg14L, and Atg6/Beclin-1 (Figure 1). Extension of the autophago-
somal membrane is then achieved with the help of two ubiquitin-
like systems (Ohsumi, 2001). In one of them Atg12 is coupled with 
the help of the E1- and E2-like enzymes Atg7 and 10 to Atg5, and 
the complex localizes then with Atg16L1 to the outer membrane of 
the emerging autophagosome. There it acts as an E3-like enzyme 
for the conjugation of the other ubiquitin-like molecule Atg8, one 
homolog of which in mammalian cells is called LC3. Atg8/LC3 is 
prior to conjugation activated by proteolytic processing through 
Atg4, exposing a glycine at its C-terminus. It is then activated by the 
E1-like enzyme Atg7, conjugated to the E2-like enzyme Atg3 and 
finally ligated to phosphatidylethanolamine in the inner and outer 
membrane of the emerging autophagosome through the E3-like 
activity of Atg12–Atg5/Atg16L1. At the autophagosomal membrane 
it mediates recruitment of ubiquitinated substrates, like protein 
aggregates and cell organelles, via the ubiquitin and LC3 bind-
ing proteins p62, NBR1, and NDP52 (Bjorkoy et al., 2005; Kirkin 
et al., 2009; Thurston et al., 2009), and probably also membrane 
fusion for autophagosomal membrane elongation and vesicle com-
pletion (Nakatogawa et al., 2007). While Atg8/LC3 remains at the 
inner autophagosomal membrane, Atg4 cleaves it from the outer 
autophagosomal membrane and also the Atg12–Atg5/Atg16L1 is 
recycled after autophagosome completion. Fusion of the completed 
autophagosomes with lysosomes and late endosomes is then also 
mediated by Atg6/Beclin-1 containing PI3 kinase complexes with 
UVRAG or Rubicon replacing Atg14L (Liang et al., 2008; Matsunaga 
et al., 2009; Zhong et al., 2009). In addition, Rab11 is required 
for fusion with late endosomes (Fader et al., 2008) and Rab7 and 
Lamp2 for fusion with lysosomes (Tanaka et al., 2000; Jager et al., 
2004). Thus the molecular machinery for macroautophagy has been 
IntroductIon
Autophagy describes a group of at least three evolutionary con-
served cellular degradation processes in eukaryotes that deliver 
cytoplasmic constituents for lysosomal degradation (Mizushima 
and Klionsky, 2007). These are macro-, micro-, and chaperone 
mediated autophagy. During microautophagy the lysosomal mem-
brane invaginates and buds into the lysosomal lumen taking a por-
tion of cytoplasm with it into lysosomal break-down. This pathway, 
however, has so far only been described in yeast and a clear dem-
onstration that it also occurs in higher eukaryotes is still lacking. 
During chaperone mediated autophagy proteins with a KFERQ rec-
ognition sequence are transported across the lysosomal membrane 
for degradation (Massey et al., 2006). For this purpose cytosolic 
chaperones, including HSC70 members, recognize KFERQ, dock 
to Lamp2a in the lysosomal membrane and are then assisted by 
another HSC70 member in the lysosomal lumen to import sub-
strates into lysosomes. This process is also conserved in higher 
eukaryotes, but it remains unclear to which extent it contributes 
to protein turn-over in the steady-state, since it has primarily been 
studied under extreme starvation conditions. Macroautophagy as 
the third pathway is characterized by de novo formation of a double-
membrane engulfed vesicle, the autophagosome, which then fuses 
with late endosomes or lysosomes for the degradation of its cargo. 
Autophagosomes can form from membranes of multiple sources, 
probably depending on the location of their cargo and initiation 
signals for vesicle formation. These membrane sources include the 
rough endoplasmic reticulum (Hayashi-Nishino et al., 2009; Yla-
Anttila Vihinen et al., 2009), the Golgi apparatus (Lynch-Day et al., 
2010; Yen et al., 2010), the outer nuclear membrane (English et al., 
2009), the outer mitochondrial membrane (He et al., 2006; Hailey 
et al., 2010), and the plasma membrane (Ravikumar et al., 2010). 
Autophagosome formation and degradation requires more than 30 
gene products, so called autophagy-related (Atg) proteins. The site 
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explored in some depth, and the gained knowledge also favored 
investigations of this particular autophagy pathway during innate 
immune responses.
Accordingly, I will primarily summarize the evidence that innate 
immune recognition regulates macroautophagy, how macroau-
tophagy modulates innate immune recognition in return, which 
effector functions for innate immunity can be mediated by macro-
autophagy and how these effector functions might restrict pathogens 
and commensals in vivo both in animal models and even in humans.
PAMP MedIAted MAcroAutoPhAgy regulAtIon
Originally macroautophagy has been described as a response to 
starvation, recycling cytoplasmic constituents to generate energy 
and macromolecular building blocks for cell survival. The signals 
leading to macroautophagy up-regulation in response to amino acid 
deprivation and growth factor withdrawal have now in part been 
described (He and Klionsky, 2009). In addition, more recently it has 
been appreciated that pathogen detection can also up-regulate mac-
roautophagy as an innate immune effector function (Mizushima 
et al., 2008). Recognition of pathogen associated molecular patterns 
(PAMPs) or pathogen induced changes in cell organelles stimu-
late macroautophagy (Figure 2). Although intuitively one would 
predict from the role of macroautophagy in cytosolic organelle 
and protein aggregate clearance that cytosolic PAMP recognition 
might preferentially enhance this pathway, but PAMP recognition 
receptors (PRRs) recognizing extra- and intra-cellular structures 
have been described to up-regulate macroautophagy. This already 
point to functions of macroautophagy beyond just engulfment 
of intracellular microbes for their degradation in lysosomes, and 
these additional effector functions of macroautophagy will be dis-
cussed in the fourth section of this review. With regard to surface 
and endosomal receptors that trigger macroautophagy mainly toll 
like receptors (TLRs) were so far evaluated for macroautophagy 
regulation (Sanjuan et al., 2007; Delgado et al., 2008; Shi and Kehrl, 
2008). Among these TLR4, the receptor for bacterial lipopolysac-
charide (LPS), and TLR7, a receptor for single stranded RNA, have 
been reported to induce the strongest autophagosome accumula-
tion in the mouse macrophage cell line RAW264.7 (Xu et al., 2007; 
Delgado et al., 2008; Shi and Kehrl, 2008). However, up-regulation 
of macroautophagy by TLR4 has less consistently been observed 
with primary bone marrow derived mouse macrophages. While 
some investigators have reported such macroautophagy increase 
(Travassos et al., 2010), others have failed to observe this (Saitoh 
et al., 2008). TLR4 recruits upon LPS engagement the adaptor mol-
ecules MyD88 and Trif, which in turn bind ubiquitinated Atg6/
Beclin-1 to enhance macroautophagy (Shi and Kehrl, 2008, 2010), 
possibly by initiating autophagosome formation at the cell mem-
brane (Ravikumar et al., 2010). Therefore, TLR signaling seems 
to up-regulate macroautophagy in mouse phagocytes, but which 
PAMPs achieve this in human cells and which pathogens relevant 
to human disease are affected by it, remains to be determined.
In addition to TLR mediated up-regulation, cytosolic PRRs have 
also been demonstrated to up-regulate macroautophagy. These are 
the bacterial peptidoglycan receptors PGRP-LE in Drosophila and 
NOD1 and two in mammalian cells (Yano et al., 2008; Cooney et al., 
2010; Travassos et al., 2010). The NOD molecules recruit Atg16L1 to 
the bacterial entry site for efficient degradation of invading patho-
gens (Travassos et al., 2010). Apart from bacterial peptidoglycan 
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FIGuRe 1 | Macroautophagy delivers cytoplasmic constituents to 
lysosomal degradation via the formation of an autophagosome. While PI3 
generated by Beclin-1 containing complexes (PI3 kinase, Beclin-1, VPS15, and 
Atg14L) marks sites of autophagosome generation, two ubiquitin-like systems 
are required to form autophagosomes at these sites. Atg12 is coupled to Atg5 
by the indicated E1-like and E2-like enzymes Atg7 and Atg10, and associates 
with the outer membrane of the emerging autophagosome in complex with 
Atg16L. The complex guides ligation as an E3-like enzyme of Atg8, whose best 
studied mammalian homolog is LC3, to the outer and inner autophagosomal 
membrane. Prior to coupling Atg8/LC3 is processed by Atg4 and activated via 
the two E1- and E2-like enzymes Atg7 and Atg3. Upon completion of the 
autophagosomes the Atgs recycle from the outer membrane, while Atg8/LC3 is 
degraded with the inner autophagosomal membrane as well as the 
autophagosome content upon fusion to lysosomes.
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Jackson et al., 2005). Furthermore, binding of the human immuno-
deficiency virus (HIV) envelope protein to the chemokine receptor 
CXCR4 augments macroautophagy and seems to enhance bystander 
T cell death for immune escape (Espert et al., 2006). Finally, pri-
marily two virus families, the herpes- and the flavi-viruses, have 
been described to enhance macroautophagy via the unfolded pro-
tein response (Sir et al., 2008; Lee et al., 2009; Dreux and Chisari, 
2010; Lin et al., 2010), and thereby gain benefits for viral replication 
and latent to lytic infection transition (Dreux et al., 2009; Lee and 
Sugden, 2008; Lee et al., 2008). In addition to these beneficial effect 
of macroautophagy up-regulation for pathogens, other microbes 
also inhibit this pathway during infection, and these immune escape 
strategies from innate effector function will be discussed below.
MAcroAutoPhAgy ModIfIcAtIon of PAMP recognItIon
While TLRs and NLRs enhance macroautophagy and little is know 
so far about C-type lectin receptor (CLR) interaction with this 
pathway, other cytosolic PAMP recognition pathways seem to be 
negatively impacted by macroautophagy (Figure 2). Along these 
lines, dsRNA recognition by RNA helicases of the family of RLRs is 
augmented in macroautophagy deficient cells (Jounai et al., 2007; 
Tal et al., 2009). The Atg12–Atg5 complex seems to directly associate 
with RIG-I and its adaptor IPS-1 to inhibit viral RNA induced type 
I IFN production (Jounai et al., 2007). Moreover, the accumulation 
of damaged mitochondria in macroautophagy deficient cells and 
the associated increase in reactive oxygen species (ROS) production, 
seem to enhance RLR activity in response to viral infections (Tal 
et al., 2009). Thus, RLR recognition of cytosolic dsRNA is attenu-
ated by macroautophagy.
Parallel to decreasing cytosolic RNA recognition, macroau-
tophagy enhances delivery of viral RNA replication intermediates 
to TLR containing endosomes (Lee et al., 2007). TLR7 dependent 
recognition of these single-stranded RNAs (ssRNAs) is essential for 
IFN-α production by vesicular stomatitis (VSV) and Sendai virus 
infected plasmacytoid dendritic cells (DCs), and depends on mac-
roautophagy (Lee et al., 2007). Similarly, endocytosed DNA seems 
to be targeted to TLR9 containing endosomes via macroautophagy 
detection, double-stranded RNA (dsRNA), a PAMP associated with 
viral replication, stimulated the IFN-inducible eIF2 kinase PKR 
(dsRNA-dependent protein kinase) to induce macroautophagy in 
herpesvirus infected cells (Talloczy et al., 2002). Therefore, PKR and 
NOD molecules seem to stimulate macroautophagy upon cytosolic 
pathogen recognition. In contrast, NOD-like receptors (NLRs) that 
give rise to inflammasomes and RIG-I like receptors (RLRs) are 
negatively regulated by macroautophagy, as will be discussed below.
In addition to direct macroautophagy up-regulation after PAMP 
recognition, cytokines that are produced in response to pathogen 
detection, have also been identified as modulators of macroau-
tophagy. Initially, IFN-γ was identified to mediate Mycobacterium 
tuberculosis clearance in part via up-regulation of macroautophagy 
(Gutierrez et al., 2004). However, similar to PRR mediated mac-
roautophagy modulation, this effect was more pronounced in the 
mouse macrophage RAW264.7 or human macrophage THP-1 and 
U937 cell lines, than in primary human or mouse macrophages 
(Harris et al., 2007). In contrast to the cell-mediated immunity 
supporting cytokine IFN-γ, cytokines associated primarily with 
humoral immune responses, like IL-4 and IL-13, seemed to rather 
inhibit macroautophagy (Harris et al., 2007). Furthermore, TNF-α 
was reported to induce macroautophagy in cells with low NF-κB 
activation (Djavaheri-Mergny et al., 2006). These included Ewing 
sarcoma cells, in which NF-κB activation was compromised and 
skeletal muscle cells (Keller et al., 2011). In good agreement with 
TNF-α induced macroautophagy in myocytes, muscle fibers of 
patients with inclusion body myositis, a myopathy with chronic 
inflammation, harbored increased numbers of autophagosomes 
and were surrounded by proinflammatory infiltrates. These find-
ings suggest that pathogen recognition can up-regulate macroau-
tophagy directly via some PRRs and indirectly via cytokines that 
are produced upon pathogen triggered immune activation.
     Unrelated to PRRs and cytokines, macroautophagy can also 
be enhanced by pathogens for their benefit. The prototypic example 
for this is poliovirus infection, during which the viral 2BC and 3A 
proteins induce the accumulation of Atg12 and Atg8/LC3 dependent 
double-membrane vesicles for viral replication (Dales et al., 1965; 
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FIGuRe 2 | Some PAMP receptors stimulate macroautophagy, while 
others are negatively regulated by it. Toll like receptors can enhance 
macroautophagy, while IPAF, component of one particular inflammasome has 
been described to inhibit autophagosome generation. Other inflammasomes are 
compromised by macroautophagy, possibly by direct degradation, and RIG-I is 
inhibited by the Atg12–Atg5 complex.
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processing of extracellular antigen by DCs was compromised by 
Atg5 deficiency in this cell subset, and this was due to diminished 
lysosomal hydrolase recruitment to endocytosed material (Lee 
et al., 2010). The enhanced phagosome maturation via Atgs seems 
to require either NADPH oxidase activity or diacylglycerol produc-
tion at the bacterial pathogen containing endosomes in mouse 
myeloid cells (Huang et al., 2009; Shahnazari and Brumell, 2009). 
However, the nature of the quality conferred by autophagosome 
or just Atg recruitment to phagosomes that allows more efficient 
fusion with lysosomes remains to be determined.
In addition to these bactericidal effector functions in endosomes, 
supported by macroautophagy, the autophagic machinery seems 
to also support bactericidal peptide release at mucosal surfaces 
(Figure 3C). Paneth cells at the base of ileal crypts suffer aberrant 
packaging and reduced exocytosis of antimicrobial granules from 
the hypomorphic down-regulation of Atg16L1 expression (Cadwell 
et al., 2008). Moreover, this aberration was only observed upon co-
infection with the murine norovirus, a positive strand RNA virus 
(Cadwell et al., 2010). Therefore, macroautophagy assistance for 
exocytosis of bactericidal granules seems to be mainly important 
during enteric infections.
An indication that these macroautophagic effector functions 
are interfering with pathogen replication is provided by the many 
mechanisms by which viruses and bacteria interfere with either 
autophagosome formation or fusion with lysosomes (Schmid 
and Münz, 2007). An exhaustive list of such pathogens and their 
immune escape strategies targeting macroautophagy is beyond the 
scope of this review and has been recently summarized elsewhere 
(Levine and Deretic, 2007). Thus, I will just high-light some gen-
in B cells (Chaturvedi et al., 2008), possibly assisting autoantibody 
production in systemic lupus erythematosus patients. These find-
ings indicate that macroautophagy enhances PAMP delivery to 
endosomal TLRs.
Among the NLRs, NOD1 and two seem to up-regulate macroau-
tophagy in mouse phagocytes and human DCs as discussed above, 
whereas signaling through other members of this family that initiate 
inflammasome formation is inhibited by macroautophagy and defi-
ciency in inflammasome components increases macroautophagy in 
Shigella flexneri infected macrophages (Suzuki et al., 2007; Saitoh 
et al., 2008). Indeed, loss of Atg16L1 increases IL-1β secretion by 
mouse macrophages, which depends on inflammasome activated 
caspase 1 processing. This increased IL-1β production worsens dex-
tran sulfate sodium induced colitis in mice. The negative regulation 
of inflammasome dependent inflammation was suggested to be 
directly mediated via inflammasome degradation by macroau-
tophagy (Harris et al., 2009), but this needs to be experimentally 
confirmed. In addition, it remains also unclear which inflammas-
omes are affected by negative regulation via macroautophagy and if 
the various inflammasome scaffolds are regulated differently. Thus, 
both RLR and inflammasome signaling in response to PAMP rec-
ognition are inhibited by macroautophagy, while the same pathway 
delivers RNA and DNA for endosomal PRRs.
effector MechAnIsMs of MAcroAutoPhAgy for 
InnAte PAthogen restrIctIon
PAMP recognition receptors mediated macroautophagy up-regu-
lation is able to exert innate restriction of intracellular pathogens, 
both those that escape endosomes and others that condition phago-
somes to become their replication compartments (Münz, 2009). 
The first pathogens described in these categories were group A 
Streptococci and Mycobacterium tuberculosis, respectively (Gutierrez 
et al., 2004; Nakagawa et al., 2004). Initially it was just assumed 
that macroautophagy delivers these pathogens for lyosomal 
degradation, thereby limiting pathogen burden in infected cells 
(Figure 3A). However, recently it has become apparent that mac-
roautophagy delivers in addition substrates that are then converted 
into bactericidal peptides by lysosomal hydrolysis (Figure 3B; 
Alonso et al., 2007; Ponpuak et al., 2010). In both instances ubiq-
uitin itself or proteins containing a ubiquitin-like domain, like the 
ribosomal protein S30 (rpS30) precursor Fau, are transported into 
Mycobacterium tuberculosis containing phagosomes to be processed 
to bactericides. In the case of Fau, binding of its ubiquitin-like 
domain to p62, which in turn recruits this ribosomal protein pre-
cursor to autophagosomes by virtue of binding to Atg8/LC3, was 
important to deliver this source of bactericidal activity to mycobac-
terial phagosomes (Ponpuak et al., 2010). Thus, macroautophagy 
does not only deliver pathogens for lysosomal hydrolysis, but also 
charges pathogen containing phagosomes with proteins that give 
rise to bactericidal peptides after lysosomal hydrolysis.
Apart from intracellular pathogen delivery to lysosomes and 
bactericidal source protein delivery to phagosomes, macroau-
tophagy seems to also enhance degradation of phagocytosed 
pathogens (Figure 3D). A role for the molecular machinery of mac-
roautophagy in the enhanced fusion of phagosomes with lysosomes 
was first identified upon TLR2 ligation in the mouse macrophage 
cell line RAW264.7 (Sanjuan et al., 2007). However, also in vivo 
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FIGuRe 3 | Macroautophagy contributes with several mechanisms to 
innate immune responses against pathogens. (A) Pathogens are directly 
taken up from the cytosol into autophagosomes and then degraded by 
lysosomal hydrolysis. (B) Substrates that give rise to bactericidal peptides 
after lysosomal degradation are transported to pathogen containing 
autophagosomes or phagosomes, and eliminate pathogens in these fusion 
vesicles. (C) Macroautophagy contributes to the release of antimicrobial 
granules from Paneth cells to restrict pathogens and commensals on mucosal 
surfaces. (D) Macroautophagy contributes to more efficient fusion of 
phagosomes with lysosomes for degradation of phagocytosed pathogens.
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 neuroattenuated with decreased lethality and faster virus clear-
ance from the brain. These data suggest that different neurotropic 
viruses are restricted by macroautophagy in neurons.
In addition to these mouse models, macroautophagy inhib-
its infection with the RNA virus VSV in flies (Shelly et al., 2009). 
Atg18 deficient Drosophila flies died rapidly after VSV infection. 
Furthermore, Drosophila uses macroautophagy to also restrict 
Listeria infection (Yano et al., 2008). These bacteria replicate to 
higher levels and kill their host flies after siRNA mediated silencing 
of Atg5. Moreover, host defense against Salmonella typhimurium 
infection in the worm Caenorhabditis elegans and the slime mold 
Dictyostelium discoideum depends in part on macroautophagy (Jia 
et al., 2009). SiRNA mediated silencing of Atg6/bec-1 and Atg8/
lgg1 in worms increased their susceptibility to Salmonella infec-
tion. Similarly, deficiency in Atg1, 6, or 7 compromised survival 
of mold to infection by the same bacterial pathogen. In both cases 
diminished macroautophagy caused higher pathogen burden in 
the infected hosts. These invertebrate models of infectious diseases, 
lacking adaptive immunity, argue for a significant innate immune 
control function by macroautophagy in vivo.
AssocIAtIon between PolyMorPhIsMs In 
MAcroAutoPhAgy genes And huMAn dIseAse
Although animal models provide strong evidence for the impor-
tance of immune mechanisms in vivo, only clinical benefit upon 
manipulation of these pathways or genetic susceptibilities for dis-
eases located in these pathways provide the final proof that some 
immune function is crucial for resistance against human pathogens. 
Along these lines, mutations in the essential macroautophagy gene 
Atg16L1, and macroautophagy stimulating genes, like immunity-
related GTPase family M (IRGM) and NOD2 (Singh et al., 2006; 
Cooney et al., 2010; Travassos et al., 2010), have been described to 
be associated with inflammatory bowel disease in Crohn’s disease 
patients (Hugot et al., 2001; Ogura et al., 2001; Hampe et al., 2007; 
Parkes et al., 2007; Rioux et al., 2007; McCarroll et al., 2008). The 
modulation of macroautophagy by the respective susceptibility 
alleles could facilitate the development of Crohn’s disease by many 
mechanisms, which have been more comprehensively summarized 
elsewhere (Meixlsperger and Münz, 2009; Stappenbeck et al., 2011). 
However, with respect to the influence of macroautophagy on 
innate immune control of commensals in the digestive tract, whose 
uncontrolled invasion could trigger inflammatory bowel disease, 
three main mechanisms might be operational. Firstly, macroau-
tophagy might simply restrict commensal bacteria in myeloid cells 
by directly targeting intracellular bacteria or assisting phagosome 
maturation of endocytosed extracellular commensals (Sanjuan 
et al., 2007; Kuballa et al., 2008; Lapaquette et al., 2010). Secondly, 
deficiencies in Paneth cells, caused by Atg16L1, which have been 
observed in Crohn’s disease patients could impair innate restriction 
of commensals at mucosal surfaces (Cadwell et al., 2008, 2010). 
Thirdly, altered macroautophagy could disturb proinflammatory 
cytokine production in mucosal tissues by up-regulating inflamma-
some dependent cytokines like IL-1β and down-regulating PAMP 
delivery for TLR stimulation and TLR dependent cytokine produc-
tion, which then in turn would limit commensal invasion (Lee 
et al., 2007; Saitoh et al., 2008). Although the exact mechanisms, 
by which the mutations in Atg16L1, IRGM, and NOD2 facilitate 
eral pathways of immune escape from autophagy by pathogens 
and discuss examples below, for which in vivo evidence for the 
importance of these has been gained. While DNA viruses, like 
Herpesviruses, seem to preferentially inhibit autophagosome 
formation, RNA viruses like HIV and influenza A virus seem to 
block autophagosome fusion with lysosomes (Gannage et al., 2009; 
Kyei et al., 2009; Gannage and Münz, 2010; Taylor et al., 2011). In 
addition, some bacterial pathogens interfere with engulfment by 
macroautophagy by either blocking bacterial protein recognition or 
covering themselves with cytosolic host cell proteins (Ogawa et al., 
2005; Yoshikawa et al., 2009). Finally, membrane pore formation 
and/or bacterial secretion systems, which inject modulators of cel-
lular physiology through endosomal membranes into the cytosol, 
seem to be required to arrest maturation of bacteria containing 
amphisomes, born from phagosome fusions with autophagosomes 
(Celli et al., 2003; Birmingham et al., 2008). Therefore, both viral 
and bacterial pathogens have developed strategies to evade mac-
roautophagy, arguing for the potency of innate restriction by this 
pathway and of its effector functions discussed above.
In vIvo restrIctIon of PAthogen InfectIon by 
MAcroAutoPhAgy
Due to the complexity of immune control mechanisms, it is 
often difficult to assign in vivo phenotypes to particular immune 
responses without underlying effects in immune compartment 
development and survival. Accentuated by the well documented 
pro-survival role of macroautophagy (Kuma et al., 2004), this is 
also an issue in case of infections and their immune control in mice 
with deficiencies in macroautophagy. Moreover, since macroau-
tophagy assists both innate and adaptive immunity (Münz, 2009) 
and macroautophagy clearly assists T cell development and T cell 
mediated immune responses in vivo (Pua et al., 2007; Nedjic et al., 
2008; Lee et al., 2010), the contributions of innate and adaptive 
pathogen restriction mechanisms via macroautophagy in verte-
brates still remain to be investigated in detail in in vivo infections. 
However, two experimental systems have been analyzed in detail 
with respect to innate immunity to viral infections via macroau-
tophagy in mice. These investigated neurotropic infections with 
the RNA virus, Sindbis Virus (SV) and the DNA virus Herpes sim-
plex virus (HSV; Orvedahl et al., 2007, 2010). Intracerebral inocu-
lation with SV causes autophagosome accumulation in neurons, 
and mortality of infected mice is increased when macroautophagy 
is inhibited by either delivering a dominant negative Atg5 protein 
with the virus, expressing cre recombinase with recombinant SV 
for deletion of floxed Atg5 in infected cells or neuron specific 
deletion of Atg5 (Orvedahl et al., 2010). Although CNS viral tit-
ers were not increased under these conditions, infection induced 
protein aggregate formation probably led to increased pathology 
and delayed virus clearance. In addition, overexpression of Atg6/
Beclin-1 in neurons protects mice from lethal intracerebral SV 
infection (Liang et al., 1998). In contrast to increased neuropathol-
ogy of SV infection without significant elevation of viral titers in 
the absence of macroautophagy, HSV inhibits macroautophagy 
to sustain high viral titers and neurovirulence (Orvedahl et al., 
2007). For this inhibition HSV encodes the ICP34.5 protein, 
which contains a domain that inhibits macroautophagy through 
binding to Atg6/Beclin-1. Deletion of this domain renders HSV 
Münz Macroautophagy during innate immune activation
www.frontiersin.org April 2011 | Volume 2 | Article 72 | 5
neurodegenerative disease in mice. 
Nature 441, 885–889.
Harris, J., De Haro, S. A., Master, S. S., 
Keane, J., Roberts, E. A., Delgado, 
M., and Deretic, V. (2007). T helper 2 
cytokines inhibit autophagic control 
of intracellular Mycobacterium tuber-
culosis. Immunity 27, 505–517.
Harris, J., Hope, J. C., and Lavelle, E. C. 
(2009). Autophagy and the immune 
response to TB. Transbound. Emerg. 
Dis. 56, 248–254.
Hayashi-Nishino, M., Fujita, N., Noda, 
T., Yamaguchi, A., Yoshimori, T., and 
Yamamoto, A. (2009). A subdomain 
of the endoplasmic reticulum forms a 
cradle for autophagosome formation. 
Nat. Cell Biol. 11, 1433–1437.
He, C., and Klionsky, D. J. (2009). 
Regulation mechanisms and signal-
ing pathways of autophagy. Annu. Rev. 
Genet. 43, 67–93.
He, C., Song, H., Yorimitsu, T., 
Monastyrska, I., Yen, W. L., Legakis, J. E., 
and Klionsky, D. J. (2006). Recruitment 
of Atg9 to the preautophagosomal 
structure by Atg11 is essential for selec-
tive autophagy in budding yeast. J. Cell 
Biol. 175, 925–935.
Huang, J., Canadien, V., Lam, G. Y., 
Steinberg, B. E., Dinauer, M. C., 
Magalhaes, M. A., Glogauer, M., 
Grinstein, S., and Brumell, J. H. (2009). 
Activation of antibacterial autophagy 
by NADPH oxidases. Proc. Natl. Acad. 
Sci. U.S.A. 106, 6226–6231.
Hugot, J. P., Chamaillard, M., Zouali, 
H., Lesage, S., Cezard, J. P., Belaiche, 
J., Almer, S., Tysk, C., O’Morain, C. 
A., Gassull, M., Binder, V., Finkel, Y., 
Cortot, A., Modigliani, R., Laurent-
Puig, P., Gower-Rousseau, C., Macry, 
J., Colombel, J. F., Sahbatou, M., and 
Thomas, G. (2001). Association of 
NOD2 leucine-rich repeat variants 
with susceptibility to Crohn’s disease. 
Nature 411, 599–603.
Jackson, W. T., Giddings, T. H. Jr., Taylor, 
M. P., Mulinyawe, S., Rabinovitch, 
M., Kopito, R. R., and Kirkegaard, 
Fader, C. M., Sanchez, D., Furlan, M., and 
Colombo, M. I. (2008). Induction of 
autophagy promotes fusion of multi-
vesicular bodies with autophagic vacu-
oles in k562 cells. Traffic 9, 230–250.
Gannage, M., Dormann, D., Albrecht, 
R., Dengjel, J., Torossi, T., Ramer, 
P. C., Lee, M., Strowig, T., Arrey, F., 
Conenello, G., Pypaert, M., Andersen, 
J., Garcia-Sastre, A., and Münz, C. 
(2009). Matrix protein 2 of influenza 
A virus blocks autophagosome fusion 
with lysosomes. Cell Host Microbe 6, 
367–380.
Gannage, M., and Münz, C. (2010). 
MHC presentation via autophagy 
and how viruses escape from it. Semin. 
Immunopathol. 32, 373–381.
Gutierrez, M. G., Master, S. S., Singh, S. 
B., Taylor, G. A., Colombo, M. I., and 
Deretic, V. (2004). Autophagy is a 
defense mechanism inhibiting BCG 
and Mycobacterium tuberculosis sur-
vival in infected macrophages. Cell 
119, 753–766.
Hailey, D. W., Rambold, A. S., Satpute-
Krishnan, P., Mitra, K., Sougrat, R., 
Kim, P. K., and Lippincott-Schwartz, 
J. (2010). Mitochondria supply mem-
branes for autophagosome biogen-
esis during starvation. Cell 141, 
656–667.
Hampe, J., Franke, A., Rosenstiel, P., Till, 
A., Teuber, M., Huse, K., Albrecht, M., 
Mayr, G., De La Vega, F. M., Briggs, 
J., Gunther, S., Prescott, N. J., Onnie, 
C. M., Hasler, R., Sipos, B., Folsch, U. 
R., Lengauer, T., Platzer, M., Mathew, 
C. G., Krawczak, M., and Schreiber, 
S. (2007). A genome-wide associa-
tion scan of nonsynonymous SNPs 
identifies a susceptibility variant for 
Crohn disease in ATG16L1. Nat. Genet. 
39, 207–211.
Hara, T., Nakamura, K., Matsui, M., 
Yamamoto, A., Nakahara, Y., Suzuki-
Migishima, R., Yokoyama, M., 
Mishima, K., Saito, I., Okano, H., and 
Mizushima, N. (2006). Suppression of 
basal autophagy in neural cells causes 
sponses to DNA-containing antigens. 
Immunity 28, 799–809.
Cooney, R., Baker, J., Brain, O., Danis, 
B., Pichulik, T., Allan, P., Ferguson, 
D. J., Campbell, B. J., Jewell, D., and 
Simmons, A. (2010). NOD2 stimula-
tion induces autophagy in dendritic 
cells influencing bacterial handling 
and antigen presentation. Nat. Med. 
16, 90–97.
Dales, S., Eggers, H. J., Tamm, I., and 
Palade, G. E. (1965). Electron micro-
scopic study of the formation of polio-
virus. Virology 26, 379–389.
Delgado, M. A., Elmaoued, R. A., Davis, 
A. S., Kyei, G., and Deretic, V. (2008). 
Toll-like receptors control autophagy. 
EMBO J. 27, 1110–1121.
Djavaheri-Mergny, M., Amelotti, M., 
Mathieu, J., Besancon, F., Bauvy, 
C., Souquere, S., Pierron, G., and 
Codogno, P. (2006). NF-kappaB 
activation represses tumor necrosis 
factor-alpha-induced autophagy. J. 
Biol. Chem. 281, 30373–30382.
Dreux, M., and Chisari, F. V. (2010). 
Viruses and the autophagy machinery. 
Cell Cycle 9, 1295–1307.
Dreux, M., Gastaminza, P., Wieland, 
S. F., and Chisari, F. V. (2009). The 
autophagy machinery is required 
to initiate hepatitis C virus replica-
tion. Proc. Natl. Acad. Sci. U.S.A. 106, 
14046–14051.
English, L., Chemali, M., Duron, J., 
Rondeau, C., Laplante, A., Gingras, 
D., Alexander, D., Leib, D., Norbury, 
C., Lippe, R., and Desjardins, M. 
(2009). Autophagy enhances the pres-
entation of endogenous viral antigens 
on MHC class I molecules during 
HSV-1 infection. Nat. Immunol. 10, 
480–487.
Espert, L., Denizot, M., Grimaldi, 
M., Robert-Hebmann, V., Gay, B., 
Varbanov, M., Codogno, P., and Biard-
Piechaczyk, M. (2006). Autophagy is 
involved in T cell death after binding 
of HIV-1 envelope proteins to CXCR4. 
J. Clin. Invest. 116, 2161–2172.
references
Alonso, S., Pethe, K., Russell, D. G., and 
Purdy, G. E. (2007). Lysosomal killing 
of Mycobacterium mediated by ubiq-
uitin-derived peptides is enhanced by 
autophagy. Proc. Natl. Acad. Sci. U.S.A. 
104, 6031–6036.
Birmingham, C. L., Canadien, V., Kaniuk, 
N. A., Steinberg, B. E., Higgins, D. E., 
and Brumell, J. H. (2008). Listeriolysin 
O allows Listeria monocytogenes repli-
cation in macrophage vacuoles. Nature 
451, 350–354.
Bjorkoy, G., Lamark, T., Brech, A., 
Outzen, H., Perander, M., Overvatn, 
A., Stenmark, H., and Johansen, T. 
(2005). p62/SQSTM1 forms protein 
aggregates degraded by autophagy and 
has a protective effect on huntingtin-
induced cell death. J. Cell Biol. 171, 
603–614.
Cadwell, K., Liu, J. Y., Brown, S. L., 
Miyoshi, H., Loh, J., Lennerz, J. K., 
Kishi, C., Kc, W., Carrero, J. A., Hunt, 
S., Stone, C. D., Brunt, E. M., Xavier, R. 
J., Sleckman, B. P., Li, E., Mizushima, 
N., Stappenbeck, T. S., and Virgin, H. 
W. IV. (2008). A key role for autophagy 
and the autophagy gene Atg16l1 in 
mouse and human intestinal Paneth 
cells. Nature 456, 259–263.
Cadwell, K., Patel, K. K., Maloney, N. S., 
Liu, T. C., Ng, A. C., Storer, C. E., Head, 
R. D., Xavier, R., Stappenbeck, T. S., 
and Virgin, H. W. (2010). Virus-plus-
susceptibility gene interaction deter-
mines Crohn’s disease gene Atg16L1 
phenotypes in intestine. Cell 141, 
1135–1145.
Celli, J., de Chastellier, C., Franchini, 
D. M., Pizarro-Cerda, J., Moreno, 
E., and Gorvel, J. P. (2003). Brucella 
evades macrophage killing via VirB-
dependent sustained interactions with 
the endoplasmic reticulum. J. Exp. 
Med. 198, 545–556.
Chaturvedi, A., Dorward, D., and Pierce, 
S. K. (2008). The B cell receptor 
governs the subcellular location of 
Toll-like receptor 9 leading to hyperre-
(Hara et al., 2006; Komatsu et al., 2006), and fight cancer (Mathew 
et al., 2009). Therefore, it would be desirable to develop therapeutic 
approaches to modulate macroautophagy in infectious and these 
other diseases. However at the moment we have very few pharmaco-
logic substances like rapamycin, most of them with significant side 
effects, to regulate macroautophagy. If more specific modulators 
could be identified this pathway could be harnessed to increase 
innate immunity among other benefits.
AcknowledgMents
Work in my laboratory is in part supported by the National Cancer 
Institute (R01CA108609 and R01CA101741), the Foundation for the 
National Institutes of Health (Grand Challenges in Global Health), 
and the Swiss National Science Foundation (310030_126995).
the  development of Crohn’s disease, still need to be characterized 
in more detail, the association of mutations in these genes strongly 
argue for an immune modulating function of this ancient catabolic 
pathway.
conclusIon
The multitude of studies summarized in this review that impli-
cate macroautophagy in pathogen restriction, escape of successful 
pathogens from this pathway, and genetic susceptibility to human 
disease due to mutations in it, suggests that macroautophagy plays 
a crucial role in both maintenance of our coexistence with gut 
commensals and resistance to infections. Apart from this roles, 
macroautophagy regulation could counteract consequences of 
aging (Zhang and Cuervo, 2008), ameliorate neurodegeneration 
Münz Macroautophagy during innate immune activation
Frontiers in Microbiology | Cellular and Infection Microbiology  April 2011 | Volume 2 | Article 72 | 6
Britton, H., Moran, T., Karaliuskas, 
R., Duerr, R. H., Achkar, J. P., Brant, 
S. R., Bayless, T. M., Kirschner, B. S., 
Hanauer, S. B., Nunez, G., and Cho, 
J. H. (2001). A frameshift mutation 
in NOD2 associated with suscepti-
bility to Crohn’s disease. Nature 411, 
603–606.
Ohsumi, Y. (2001). Molecular dissec-
tion of autophagy: two ubiquitin-like 
systems. Nat. Rev. Mol. Cell Biol. 2, 
211–216.
Orvedahl, A., Alexander, D., Talloczy, Z., 
Sun, Q., Wei, Y., Zhang, W., Burns, D., 
Leib, D., and Levine, B. (2007). HSV-1 
ICP34.5 confers neurovirulence by 
targeting the Beclin 1 autophagy pro-
tein. Cell Host Microbe 1, 23–35.
Orvedahl, A., MacPherson, S., Sumpter, 
R. Jr., Talloczy, Z., Zou, Z., and Levine, 
B. (2010). Autophagy protects against 
Sindbis virus infection of the central 
nervous system. Cell Host Microbe 7, 
115–127.
Parkes, M., Barrett, J. C., Prescott, N. 
J., Tremelling, M., Anderson, C. A., 
Fisher, S. A., Roberts, R. G., Nimmo, 
E. R., Cummings, F. R., Soars, 
D., Drummond, H., Lees, C. W., 
Khawaja, S. A., Bagnall, R., Burke, 
D. A., Todhunter, C. E., Ahmad, T., 
Onnie, C. M., McArdle, W., Strachan, 
D., Bethel, G., Bryan, C., Lewis, C. M., 
Deloukas, P., Forbes, A., Sanderson, 
J., Jewell, D. P., Satsangi, J., Mansfield, 
J. C., Cardon, L., and Mathew, C. 
G. (2007). Sequence variants in the 
autophagy gene IRGM and multiple 
other replicating loci contribute to 
Crohn’s disease susceptibility. Nat. 
Genet. 39, 830–832.
Ponpuak, M., Davis, A. S., Roberts, E. A., 
Delgado, M. A., Dinkins, C., Zhao, Z., 
Virgin, H. W. t., Kyei, G. B., Johansen, 
T., Vergne, I., and Deretic, V. (2010). 
Delivery of cytosolic components 
by autophagic adaptor protein p62 
endows autophagosomes with unique 
antimicrobial properties. Immunity 
32, 329–341.
Pua, H. H., Dzhagalov, I., Chuck, M., 
Mizushima, N., and He, Y. W. (2007). 
A critical role for the autophagy gene 
Atg5 in T cell survival and prolifera-
tion. J. Exp. Med. 204, 25–31.
Ravikumar, B., Moreau, K., Jahreiss, L., 
Puri, C., and Rubinsztein, D. C. (2010). 
Plasma membrane contributes to the 
formation of pre-autophagosomal 
structures. Nat. Cell Biol. 12, 747–757.
Rioux, J. D., Xavier, R. J., Taylor, K. D., 
Silverberg, M. S., Goyette, P., Huett, A., 
Green, T., Kuballa, P., Barmada, M. M., 
Datta, L. W., Shugart, Y. Y., Griffiths, 
A. M., Targan, S. R., Ippoliti, A. F., 
Bernard, E. J., Mei, L., Nicolae, D. L., 
Regueiro, M., Schumm, L. P., Steinhart, 
A. H., Rotter, J. I., Duerr, R. H., Cho, J. 
H., Daly, M. J., and Brant, S. R. (2007). 
autophagy in aging and disease. Curr. 
Top. Dev. Biol. 73, 205–235.
Mathew, R., Karp, C. M., Beaudoin, 
B., Vuong, N., Chen, G., Chen, H. 
Y., Bray, K., Reddy, A., Bhanot, G., 
Gelinas, C., Dipaola, R. S., Karantza-
Wadsworth, V., and White, E. (2009). 
Autophagy suppresses tumorigenesis 
through elimination of p62. Cell 137, 
1062–1075.
Matsunaga, K., Saitoh, T., Tabata, K., 
Omori, H., Satoh, T., Kurotori, N., 
Maejima, I., Shirahama-Noda, K., 
Ichimura, T., Isobe, T., Akira, S., 
Noda, T., and Yoshimori, T. (2009). 
Two Beclin 1-binding proteins, Atg14L 
and Rubicon, reciprocally regulate 
autophagy at different stages. Nat. 
Cell Biol. 11, 385–396.
McCarroll, S. A., Huett, A., Kuballa, P., 
Chilewski, S. D., Landry, A., Goyette, 
P., Zody, M. C., Hall, J. L., Brant, S. R., 
Cho, J. H., Duerr, R. H., Silverberg, M. 
S., Taylor, K. D., Rioux, J. D., Altshuler, 
D., Daly, M. J., and Xavier, R. J. (2008). 
Deletion polymorphism upstream of 
IRGM associated with altered IRGM 
expression and Crohn’s disease. Nat. 
Genet. 40, 1107–1112.
Meixlsperger, S., and Münz, C. (2009). 
Morbus Crohn – a disease of failing 
macroautophagy in the immune sys-
tem? Int. Immunol. 21, 1205–1211.
Mizushima, N., and Klionsky, D. J. (2007). 
Protein turnover via autophagy: impli-
cations for metabolism. Annu. Rev. 
Nutr. 27, 19–40.
Mizushima, N., Levine, B., Cuervo, A. M., 
and Klionsky, D. J. (2008). Autophagy 
fights disease through cellular self-
digestion. Nature 451, 1069–1075.
Münz, C. (2009). Enhancing immu-
nity through autophagy. Annu. Rev. 
Immunol. 27, 423–429.
Nakagawa, I., Amano, A., Mizushima, 
N., Yamamoto, A., Yamaguchi, H., 
Kamimoto, T., Nara, A., Funao, J., 
Nakata, M., Tsuda, K., Hamada, S., 
and Yoshimori, T. (2004). Autophagy 
defends cells against invading group A 
Streptococcus. Science 306, 1037–1040.
Nakatogawa, H., Ichimura, Y., and Ohsumi, 
Y. (2007). Atg8, a ubiquitin-like protein 
required for autophagosome forma-
tion, mediates membrane tethering 
and hemifusion. Cell 130, 165–178.
Nedjic, J., Aichinger, M., Emmerich, J., 
Mizushima, N., and Klein, L. (2008). 
Autophagy in thymic epithelium 
shapes the T-cell repertoire and is 
essential for tolerance. Nature 455, 
396–400.
Ogawa, M., Yoshimori, T., Suzuki, T., 
Sagara, H., Mizushima, N., and 
Sasakawa, C. (2005). Escape of intra-
cellular Shigella from autophagy. 
Science 307, 727–731.
Ogura, Y., Bonen, D. K., Inohara, N., 
Nicolae, D. L., Chen, F. F., Ramos, R., 
yields in macrophages. J. Cell Biol. 186, 
255–268.
Lapaquette, P., Glasser, A. L., Huett, A., 
Xavier, R. J., and Darfeuille-Michaud, 
A. (2010). Crohn’s disease-associated 
adherent-invasive E. coli are selectively 
favoured by impaired autophagy to 
replicate intracellularly. Cell Microbiol. 
12, 99–113.
Lee, D. Y., Lee, J., and Sugden, B. (2009). 
The unfolded protein response and 
autophagy: herpesviruses rule! J. Virol. 
83, 1168–1172.
Lee, D. Y., and Sugden, B. (2008). The 
latent membrane protein 1 onco-
gene modifies B-cell physiology by 
regulating autophagy. Oncogene 27, 
2833–2842.
Lee, H. K., Lund, J. M., Ramanathan, B., 
Mizushima, N., and Iwasaki, A. (2007). 
Autophagy-dependent viral recogni-
tion by plasmacytoid dendritic cells. 
Science 315, 1398–1401.
Lee, H. K., Mattei, L. M., Steinberg, B. 
E., Alberts, P., Lee, Y. H., Chervonsky, 
A., Mizushima, N., Grinstein, S., and 
Iwasaki, A. (2010). In vivo requirement 
for Atg5 in antigen presentation by 
dendritic cells. Immunity 32, 227–239.
Lee, Y. R., Lei, H. Y., Liu, M. T., Wang, 
J. R., Chen, S. H., Jiang-Shieh, Y. 
F., Lin, Y. S., Yeh, T. M., Liu, C. C., 
and Liu, H. S. (2008). Autophagic 
machinery activated by dengue virus 
enhances virus replication. Virology 
374, 240–248.
Levine, B., and Deretic, V. (2007). 
Unveiling the roles of autophagy in 
innate and adaptive immunity. Nat. 
Rev. Immunol. 7, 767–777.
Liang, C., Lee, J. S., Inn, K. S., Gack, M. 
U., Li, Q., Roberts, E. A., Vergne, I., 
Deretic, V., Feng, P., Akazawa, C., and 
Jung, J. U. (2008). Beclin1-binding 
UVRAG targets the class C Vps com-
plex to coordinate autophagosome 
maturation and endocytic trafficking. 
Nat. Cell Biol. 10, 776–787.
Liang, X. H., Kleeman, L. K., Jiang, H. H., 
Gordon, G., Goldman, J. E., Berry, G., 
Herman, B., and Levine, B. (1998). 
Protection against fatal Sindbis virus 
encephalitis by beclin, a novel Bcl-
2-interacting protein. J. Virol. 72, 
8586–8596.
Lin, L. T., Dawson, P. W., and Richardson, 
C. D. (2010). Viral interactions with 
macroautophagy: a double-edged 
sword. Virology 402, 1–10.
Lynch-Day, M. A., Bhandari, D., Menon, 
S., Huang, J., Cai, H., Bartholomew, 
C. R., Brumell, J. H., Ferro-Novick, 
S., and Klionsky, D. J. (2010). Trs85 
directs a Ypt1 GEF, TRAPPIII, to the 
phagophore to promote autophagy. 
Proc. Natl. Acad. Sci. U.S.A. 107, 
7811–7816.
Massey, A. C., Zhang, C., and Cuervo, 
A. M. (2006). Chaperone-mediated 
K. (2005). Subversion of cellular 
autophagosomal machinery by 
RNA viruses. PLoS Biol. 3, e156. doi: 
10.1371/journal.pbio.0030156
Jager, S., Bucci, C., Tanida, I., Ueno, T., 
Kominami, E., Saftig, P., and Eskelinen, 
E. L. (2004). Role for Rab7 in matura-
tion of late autophagic vacuoles. J. Cell. 
Sci. 117(Pt 20), 4837–4848.
Jia, K., Thomas, C., Akbar, M., Sun, Q., 
Adams-Huet, B., Gilpin, C., and 
Levine, B. (2009). Autophagy genes 
protect against Salmonella typhimu-
rium infection and mediate insulin 
signaling-regulated pathogen resist-
ance. Proc. Natl. Acad. Sci. U.S.A. 106, 
14564–14569.
Jounai, N., Takeshita, F., Kobiyama, K., 
Sawano, A., Miyawaki, A., Xin, K. Q., 
Ishii, K. J., Kawai, T., Akira, S., Suzuki, 
K., and Okuda, K. (2007). The Atg5 
Atg12 conjugate associates with 
innate antiviral immune responses. 
Proc. Natl. Acad. Sci. U.S.A. 104, 
14050–14055.
Keller, C. W., Fokken, C., Turville, S. G., 
Lünemann, A., Schmidt, J., Münz, C., 
and Lünemann, J. D. (2011). TNF-
alpha induces macroautophagy and 
regulates MHC class II expression in 
human skeletal muscle cells. J. Biol. 
Chem. 286, 3970–3980.
Kirkin, V., Lamark, T., Sou, Y. S., Bjorkoy, 
G., Nunn, J. L., Bruun, J. A., Shvets, E., 
McEwan, D. G., Clausen, T. H., Wild, P., 
Bilusic, I., Theurillat, J. P., Overvatn, A., 
Ishii, T., Elazar, Z., Komatsu, M., Dikic, 
I., and Johansen, T. (2009). A role for 
NBR1 in autophagosomal degrada-
tion of ubiquitinated substrates. Mol. 
Cell 33, 505–516.
Komatsu, M., Waguri, S., Chiba, T., 
Murata, S., Iwata, J., Tanida, I., 
Ueno, T., Koike, M., Uchiyama, Y., 
Kominami, E., and Tanaka, K. (2006). 
Loss of autophagy in the central nerv-
ous system causes neurodegeneration 
in mice. Nature 441, 880–884.
Kuballa, P., Huett, A., Rioux, J. D., Daly, M. 
J., and Xavier, R. J. (2008). Impaired 
autophagy of an intracellular patho-
gen induced by a Crohn’s disease 
associated ATG16L1 variant. PLoS 
ONE 3, e3391. doi: 10.1371/journal.
pone.0003391
Kuma, A., Hatano, M., Matsui, M., 
Yamamoto, A., Nakaya, H., Yoshimori, 
T., Ohsumi, Y., Tokuhisa, T., and 
Mizushima, N. (2004). The role of 
autophagy during the early neona-
tal starvation period. Nature 432, 
1032–1036.
Kyei, G. B., Dinkins, C., Davis, A. S., 
Roberts, E., Singh, S. B., Dong, C., Wu, 
L., Kominami, E., Ueno, T., Yamamoto, 
A., Federico, M., Panganiban, A., 
Vergne, I., and Deretic, V. (2009). 
Autophagy pathway intersects with 
HIV-1 biosynthesis and regulates viral 
Münz Macroautophagy during innate immune activation
www.frontiersin.org April 2011 | Volume 2 | Article 72 | 7
Yoshikawa, Y., Ogawa, M., Hain, T., 
Yoshida, M., Fukumatsu, M., Kim, M., 
Mimuro, H., Nakagawa, I., Yanagawa, 
T., Ishii, T., Kakizuka, A., Sztul, E., 
Chakraborty, T., and Sasakawa, C. 
(2009). Listeria monocytogenes ActA-
mediated escape from autophagic rec-
ognition. Nat. Cell Biol. 11, 1233–1240.
Zhang, C., and Cuervo, A. M. (2008). 
Restoration of chaperone-mediated 
autophagy in aging liver improves cel-
lular maintenance and hepatic func-
tion. Nat. Med. 14, 959–965.
Zhong, Y., Wang, Q. J., Li, X., Yan, Y., 
Backer, J. M., Chait, B. T., Heintz, N., 
and Yue, Z. (2009). Distinct regula-
tion of autophagic activity by Atg14L 
and Rubicon associated with Beclin 
1-phosphatidylinositol-3-kinase 
complex. Nat. Cell Biol. 11, 468–476.
Conflict of Interest Statement: The 
author declares that the research was 
conducted in the absence of any com-
mercial or financial relationships that 
could be construed as a potential conflict 
of interest.
Received: 22 October 2010; paper pending 
published: 16 November 2010; accepted: 
28 March 2011; published online: 12 April 
2011.
Citation: Münz C (2011) Macroautophagy 
during innate immune activation. 
Front. Microbio. 2:72. doi: 10.3389/
fmicb.2011.00072
This article was submitted to Frontiers in 
Cellular and Infection Microbiology, a spe-
cialty of Frontiers in Microbiology.
Copyright © 2011 Münz. This is an open-
access article subject to a non-exclusive license 
between the authors and Frontiers Media 
SA, which permits use, distribution and 
reproduction in other forums, provided the 
original authors and source are credited and 
other Frontiers conditions are complied with.
Taylor, G. S., Mautner, J., and Münz, C. 
(2011). Autophagy in herpesvirus 
immune control and immune escape. 
Herpesviridae 2, 2.
Thurston, T. L., Ryzhakov, G., Bloor, S., von 
Muhlinen, N., and Randow, F. (2009). 
The TBK1 adaptor and autophagy 
receptor NDP52 restricts the prolif-
eration of ubiquitin-coated bacteria. 
Nat. Immunol. 10, 1215–1221.
Travassos, L. H., Carneiro, L. A., Ramjeet, 
M., Hussey, S., Kim, Y. G., Magalhaes, 
J. G., Yuan, L., Soares, F., Chea, E., Le 
Bourhis, L., Boneca, I. G., Allaoui, A., 
Jones, N. L., Nunez, G., Girardin, S. E., 
and Philpott, D. J. (2010). Nod1 and 
Nod2 direct autophagy by recruiting 
ATG16L1 to the plasma membrane 
at the site of bacterial entry. Nat. 
Immunol. 11, 55–62.
Xu, Y., Jagannath, C., Liu, X. D., 
Sharafkhaneh, A., Kolodziejska, K. E., 
and Eissa, N. T. (2007). Toll-like recep-
tor 4 is a sensor for autophagy associ-
ated with innate immunity. Immunity 
27, 135–144.
Yano, T., Mita, S., Ohmori, H., Oshima, 
Y., Fujimoto, Y., Ueda, R., Takada, 
H., Goldman, W. E., Fukase, K., 
Silverman, N., Yoshimori, T., and 
Kurata, S. (2008). Autophagic control 
of listeria through intracellular innate 
immune recognition in Drosophila. 
Nat. Immunol. 9, 908–916.
Yen, W. L., Shintani, T., Nair, U., Cao, Y., 
Richardson,B., C., Li, Z., Hughson, 
F. M., Baba, M., and Klionsky, D. J. 
(2010). The conserved oligomeric 
Golgi complex is involved in double-
membrane vesicle formation during 
autophagy. J. Cell Biol. 188, 101–114.
Yla-Anttila, P., Vihinen, H., Jokitalo, E., 
and Eskelinen, E. L. (2009). 3D tom-
ography reveals connections between 
the phagophore and endoplasmic 
reticulum. Autophagy 5, 1180–1185.
 intracellular mycobacteria. Science 
313, 1438–1441.
Sir, D., Chen, W. L., Choi, J., Wakita, 
T., Yen, T. S., and Ou, J. H. (2008). 
Induction of incomplete autophagic 
response by hepatitis C virus via the 
unfolded protein response. Hepatology 
48, 1054–1061.
Stappenbeck, T. S., Rioux, J. D., Mizoguchi, 
A., Saitoh, T., Huett, A., Darfeuille-
Michaud, A., Wileman, T., Mizushima, 
N., Carding, S., Akira, S., Parkes, M., 
and Xavier, R. J. (2011). Crohn disease: 
a current perspective on genetics, 
autophagy and immunity. Autophagy 
7, 355–374.
Suzuki, T., Franchi, L., Toma, C., Ashida, 
H., Ogawa, M., Yoshikawa, Y., Mimuro, 
H., Inohara, N., Sasakawa, C., and 
Nunez, G. (2007). Differential regula-
tion of caspase-1 activation, pyropto-
sis, and autophagy via Ipaf and ASC in 
Shigella-infected macrophages. PLoS 
Pathog. 3, e111. doi: 10.1371/journal.
ppat.0030111
Tal, M. C., Sasai, M., Lee, H. K., Yordy, B., 
Shadel, G. S., and Iwasaki, A. (2009). 
Absence of autophagy results in reac-
tive oxygen species-dependent ampli-
fication of RLR signaling. Proc. Natl. 
Acad. Sci. U.S.A. 106, 2770–2775.
Talloczy, Z., Jiang, W., Virgin, H. W. IV, 
Leib, D. A., Scheuner, D., Kaufman, 
R. J., Eskelinen, E. L., and Levine, B. 
(2002). Regulation of starvation- 
and virus-induced autophagy by 
the eIF2alpha kinase signaling path-
way. Proc. Natl. Acad. Sci. U.S.A. 99, 
190–195.
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, 
E. L., Hartmann, D., Lullmann-Rauch, 
R., Janssen, P. M., Blanz, J., von Figura, 
K., and Saftig, P. (2000). Accumulation 
of autophagic vacuoles and cardiomy-
opathy in LAMP-2-deficient mice. 
Nature 406, 902–906.
Genome-wide association study iden-
tifies new susceptibility loci for Crohn 
disease and implicates autophagy in 
disease pathogenesis. Nat. Genet. 39, 
596–604.
Saitoh, T., Fujita, N., Jang, M. H., Uematsu, 
S., Yang, B. G., Satoh, T., Omori, H., 
Noda, T., Yamamoto, N., Komatsu, 
M., Tanaka, K., Kawai, T., Tsujimura, 
T., Takeuchi, O., Yoshimori, T., and 
Akira, S. (2008). Loss of the autophagy 
protein Atg16L1 enhances endotoxin-
induced IL-1beta production. Nature 
456, 264–268.
Sanjuan, M. A., Dillon, C. P., Tait, S. W., 
Moshiach, S., Dorsey, F., Connell, S., 
Komatsu, M., Tanaka, K., Cleveland, J. 
L., Withoff, S., and Green, D. R. (2007). 
Toll-like receptor signalling in macro-
phages links the autophagy pathway to 
phagocytosis. Nature 450, 1253–1257.
Schmid, D., and Münz, C. (2007). Innate 
and adaptive immunity through 
autophagy. Immunity 26, 11–21.
Shahnazari, S., and Brumell, J. H. (2009). 
Eating twice for the sake of immunity: 
a phagocytic receptor that activates 
autophagy. Cell Host Microbe 6, 297–298.
Shelly, S., Lukinova, N., Bambina, S., 
Berman, A., and Cherry, S. (2009). 
Autophagy is an essential compo-
nent of Drosophila immunity against 
vesicular stomatitis virus. Immunity 
30, 588–598.
Shi, C. S., and Kehrl, J. H. (2008). MyD88 
and Trif target Beclin 1 to trigger 
autophagy in macrophages. J. Biol. 
Chem. 283, 33175–33182.
Shi, C. S., and Kehrl, J. H. (2010). TRAF6 
and A20 regulate lysine 63-linked 
ubiquitination of Beclin-1 to control 
TLR4-induced autophagy. Sci. Signal. 
3, ra42.
Singh, S. B., Davis, A. S., Taylor, G. A., 
and Deretic, V. (2006). Human 
IRGM induces autophagy to eliminate 
Münz Macroautophagy during innate immune activation
Frontiers in Microbiology | Cellular and Infection Microbiology  April 2011 | Volume 2 | Article 72 | 8
